Ventyx Biosciences, Inc.
US ˙ NasdaqGS ˙ US92332V1070
ESTE SÍMBOLO NÃO ESTÁ MAIS ATIVO

SecurityVTYX / Ventyx Biosciences, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership10,235 shares
Latest Disclosed Value $ 21,902
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 90.00% decrease in ownership of VTYX / Ventyx Biosciences, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 10,235 shares of Ventyx Biosciences, Inc. (US:VTYX) valued at $21,903 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 102,341 shares of Ventyx Biosciences, Inc.. This represents a change in shares of -90.00% during the quarter. The current value of the position is $143,290 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Ventyx Biosciences EC US92332V1070 10,235 -92,106 -90.00 22 -82.05 0.0005
2025-05-28 2025-03-31 NP Ventyx Biosciences EC US92332V1070 102,341 0 0.00 118 -47.77 0.0028
2025-02-25 2024-12-31 NP Ventyx Biosciences EC US92332V1070 102,341 -18,836 -15.54 224 -15.15 0.0049
2024-11-26 2024-09-30 NP Ventyx Biosciences EC US92332V1070 121,177 29,446 32.10 264 25.12 0.0050
2024-08-26 2024-06-30 NP Ventyx Biosciences EC US92332V1070 91,731 8,527 10.25 212 -53.83 0.0043
2024-05-28 2024-03-31 NP Ventyx Biosciences EC US92332V1070 83,204 0 0.00 458 122.93 0.0095
2024-02-26 2023-12-31 NP Ventyx Biosciences EC US92332V1070 83,204 3,845 4.85 206 -92.56 0.0044
2023-11-28 2023-09-30 NP Ventyx Biosciences EC US92332V1070 79,359 -1,419 -1.76 2,756 4.04 0.0719
2023-08-25 2023-06-30 NP Ventyx Biosciences EC US92332V1070 80,778 40,802 102.07 2,650 97.83 0.0628
2023-05-26 2023-03-31 NP Ventyx Biosciences EC US92332V1070 39,976 1,087 2.80 1,339 5.02 0.0357
2023-02-24 2022-12-31 NP Ventyx Biosciences EC US92332V1070 38,889 304 0.79 1,275 -5.35 0.0351
2022-11-25 2022-09-30 NP Ventyx Biosciences EC US92332V1070 38,585 3,959 11.43 1,347 218.44 0.0386
2022-08-25 2022-06-30 NP Ventyx Biosciences EC US92332V1070 34,626 18,007 108.35 423 88.00 0.0117
2022-05-26 2022-03-31 NP Ventyx Biosciences EC US92332V1070 16,619 2,662 19.07 226 -18.77 0.0053
2022-02-25 2021-12-31 NP Ventyx Biosciences EC US92332V1070 13,957 13,957 277 0.0060
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.